Notice2022-28186

National Cancer Institute; Amended Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 28, 2022

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 248 (Wednesday, December 28, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Page 79896]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-28186]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, TEP-8A: SBIR Contract Review, 
February 1, 2023, 9:30 a.m. to 5:30 p.m., National Cancer Institute at 
Shady Grove, Room 7W030, 9609 Medical Center Drive, Rockville, 
Maryland, 20850 which was published in the Federal Register on December 
19, 2022, FR Doc 2022-27417, 87 FR 77624.
    This notice is being amended to change the meeting time from 9:30 
a.m.-5:30 p.m. to 10:00 a.m.-2:00 p.m. on February 1, 2023. The meeting 
date and location will stay the same. The meeting is closed to public.

    Dated: December 21, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-28186 Filed 12-27-22; 8:45 am]
BILLING CODE 4140-01-P


</pre></body>
</html>
Indexed from Federal Register on December 28, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.